Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Resource Type
Article
Authors
Zhu, Fengcai ; Zhuang, Chunlan ; Chu, Kai ; Zhang, Liang ; Zhao, Hui ; Huang, Shoujie ; Su, Yingying ; Lin, Hongyan ; Yang, Changlin ; Jiang, Hanmin ; Zang, Xia ; Liu, Donglin ; Pan, Hongxing ; Hu, Yuemei ; Liu, Xiaohui ; Chen, Qi ; Song, Qiaoqiao ; Quan, Jiali ; Huang, Zehong ; Zhong, Guohua ; Chen, Junyu ; Han, Jinle ; Sun, Hong ; Cui, Lunbiao ; Li, Jingxin ; Chen, Yixin ; Zhang, Tianying ; Ye, Xiangzhong ; Li, Changgui ; Wu, Ting ; Zhang, Jun ; Xia, Ning-Shao
Source
In The Lancet Respiratory Medicine August 2022 10(8):749-760
Subject
Primary Research Articles
Language
ISSN
2213-2600